In a study looking at BRCA2 reversion mutations in mCRPC, a large genomic database identified 24 gBRCAm patients out of 1534 mCRPC patients undergoing circulating tumour DNA (ctDNA) testing. Here, BRCA2 is linked to neoplasm.